IART · Integra Lifesciences Holdings Corp · Debt

$11.91 -0.42 (-3.37%)

Market Cap

$958.55M

77.77M

Volume · Oct 23 1.21M Avg daily vol (3M) 965.53K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Long-term debt, including current maturities	2026-06-30	USD 707,187,000	10-Q filed 2026-07-29
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current portion of secured debt USD 43,594,000 Noncurrent secured debt USD 1,736,105,000
Operating lease liabilities	2026-06-30	USD 176,580,000	10-Q filed 2026-07-29
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 13,920,000 Noncurrent operating lease liabilities USD 162,660,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 917520 CUSIP 457985208 13F (30d) 26 filings 26 filers Visit website Investor relations